ABCA1: The gatekeeper for eliminating excess tissue cholesterol

Journal of Lipid Research

Volumn 42, Issue 8, 2001, Pages 1173-1179

  Oram, John F ^a   Lawn, Richard M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CV THERAPEUTICS INC   (United States)

Author keywords

ABCA1 gene regulation; Cardiovascular disease; Cellular cholesterol trafficking; Cholesterol efflux; HDL; LXR; Phospholipid efflux; Reverse cholesterol transport; Tangier disease

Indexed keywords

ABC TRANSPORTER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION; TANGIER DISEASE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, HDL; MUTATION; TANGIER DISEASE;

EID: 0034879774     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture
2. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease
3. The plasma lecithins: Cholesterol acyltransferase reaction
4. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
5. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
6. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
7. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
8. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
9. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
10. Regulation of intracellular trafficking of ABCA1
11. Insights derived from mutations in ABCA1 in humans and animal models
12. An inventory of the human ABC proteins
13. The human ATP-binding cassette (ABC) transporter superfamily
14. Distantly related sequences in the α and β subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold
15. Cloning of two novel ABC transporters mapping on human chromosome 9
16. Apolipoprotein-mediated cellular cholesterol efflux
17. Cell cholesterol efflux: Integration of old and new observations provides new insights
18. Tangier disease and ABCA1
19. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis
20. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol
21. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy
22. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface
23. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages
24. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts
25. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol
26. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects
27. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients
28. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway
29. Cholesterol efflux to apolipo-protein A-I involves endocytosis and resecretion in a calcium-dependent pathway
30. Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency
31. Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds
32. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux
33. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease
34. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux
35. Familial high density lipoprotein deficiency: Tangier disease
36. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice
37. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
38. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency
39. Massive cholesterol ester accumulation in hepatocytes and intestinal epithelial cells caused by ABC1 mutation in WHAM chickens
40. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease
41. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins
42. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)
43. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency
44. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
45. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
46. Synthetic amphipathic helical peptides that mimic apolipoprotein A-1 in clearing cellular cholesterol
47. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion
48. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: Lack of effect with Tangier disease cells
49. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
50. Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter
51. Analysis of hABC1 gene 5′ end: Additional peptide sequence, promoter region, and four polymorphisms
52. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
53. ABC1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR
54. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha
55. Nuclear receptor regulation of cholesterol and bile acid metabolism
56. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
57. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
58. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
59. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
60. Role of LXRs in control of lipogenesis
61. The zinc finger protein 202 (znf202) is a transcriptional repressor of atp binding cassette transporter a1 (abca1) and abcg1 gene expression and a modulator of cellular lipid efflux
62. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors
63. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-1 by cAMP
64. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
65. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages
66. Identification of cAMP analogue inducible genes in RAW264 macrophages
67. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells
68. Localization of human atp-binding cassette transporter 1 (abc1) in normal and atherosclerotic tissues
69. Accumulation of dietary, cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
70. Regulation and activity of the human ABCA1 gene in transgenic mice
71. ABCA1 contains an N-terminal signal-anchor sequence that translocates the proteins first hydrophilic domain to the exoplasmic space